JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DE BEER, E. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DE BEER, E. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 85, Issue 1, 1-13, 1945
Copyright © 1945 by American Society for Pharmacology and Experimental Therapeutics

THE CALCULATION OF BIOLOGICAL ASSAY RESULTS BY GRAPHIC METHODS. THE ALL-OR-NONE TYPE OF RESPONSE

EDWIN J. DE BEER 1

1 From the Wellcome Research Laboratories, Tuckahoc, N. Y.

1. The LD50, slope and error of dose-response curves for the all-or-none type of data may be rapidly calculated with the aid of a series of scales and nomographs.

2. The potency and its associated error for assays involving data of the all-or-none type may also be calculated with these scales.

3. The construction of the scales and nomographs is described and their use is illustrated by an example.3

Submitted on December 18, 1944




This article has been cited by other articles:


Home page
 ScienceHome page
J. F. Reinhard, E. T. Kimura, and R. J. Schachter
Some Pharmacologic Characteristics of Isonicotinyl Hydrazide (Pyricidin(R)), A New Antituberculosis Drug
Science, August 15, 1952; 116(3007): 166 - 167.
[PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1945 by the American Society for Pharmacology and Experimental Therapeutics.